8VC

Latent Labs is a pioneering AI laboratory specializing in programmable biology. It develops advanced generative AI models that capture the core principles of biology, empowering healthcare partners to create novel antibodies, optimize existing enzymes, and advance genetic engineering. This enables partners to gain unparalleled control over molecular biology, driving transformative advancements in health and sustainability.

Founded in San Francisco, Sirona Medical develops a cloud-native platform designed specifically for radiologists. This platform unifies worklist, viewer, reporter, archive, and AI into a single workspace, simplifying complex workflows, enhancing productivity, and empowering practitioners to deliver better, faster care.

SurgLogs Inc. is a software developer based in San Diego, California, specializing in compliance-related solutions for ambulatory surgery centers and healthcare facilities. Founded in 2015, the company provides a digital platform that replaces traditional pen-and-paper methods with a HIPAA-compliant application and an administrative dashboard. This platform organizes and automates the management of logbooks, medications, supplies, in-services, and drills, enhancing efficiency and reducing paperwork for healthcare organizations. SurgLogs offers features such as device authorization, automated daily checks and notifications, and electronic report export services, catering to doctors, nurses, and healthcare administrators. By streamlining compliance processes, SurgLogs enables its clients to maintain regulatory standards effectively and manage operations more efficiently.

Seen Health operates a healthcare service focused on empowering older adults to age with dignity in their communities. It specializes in culturally-focused, technology-enabled services that integrate medical care and social support.

Candid Health is a platform that automates revenue cycle management for healthcare providers by integrating with existing infrastructure and using machine learning and artificial intelligence to streamline medical billing, coding, and claims processing. It delivers end-to-end automation to reduce administrative burdens, increase operational efficiency, and accelerate reimbursement, enabling clinics and hospitals to focus more on delivering high-quality, affordable care.

Hopscotch Primary Care is a healthcare company focused on transforming rural healthcare through data-driven, team-based care that expands access and improves quality for patients in rural communities. The organization delivers tailored quality care via a collaborative model and provides resources and support for patients inside and outside clinics, enabling clinicians to offer the right care and continuity of service.

Amber Therapeutics specializes in developing advanced bioelectronic therapies that can sense and adapt, aiming to enhance clinical outcomes for patients with functional disorders of the peripheral nervous system.

Luminate Medical specializes in developing innovative medical devices aimed at preventing hair loss during chemotherapy. Recognizing the significant impact of hair loss on patients' self-esteem, the company focuses on utilizing advanced medical technology to protect this essential element of personality.

Latus Bio is a biotechnology company dedicated to developing innovative gene therapies for neurological diseases. It specializes in novel discovery approaches using non-human primate models, enabling precise delivery of therapeutic genes to targeted cells within the central nervous system. Latus Bio aims to enhance clinical safety and manufacturing efficiency by administering low doses of its proprietary adeno-associated virus (AAV) capsids.

Amae Health is a clinic specializing in mental wellness care for individuals with severe mental illnesses. It offers tailored treatments across behavioral medicine, primary care, and social health services, aiming to stabilize patients, enhance their well-being, and prevent future crises. The company's integrated care platform is designed to address the unique needs of its patients, enabling improved health outcomes.

Oula Health, Inc. is a maternity care provider based in Brooklyn, New York, established in 2019. The company focuses on redesigning maternity care by integrating obstetrics and midwifery to create a personalized and evidence-based experience for expecting families. Oula operates clinics and offers home-based prenatal care services, aiming to set a new standard for pregnancy care that harmonizes modern medical practices with a compassionate approach. Through its innovative model, Oula Health seeks to enhance the overall maternity care experience for its clients.

Unlearn.AI, Inc. is a biotechnology company based in San Francisco, California, that specializes in developing innovative software tools for clinical research. Established in 2017, Unlearn.AI focuses on enhancing clinical trials through its unique digital twin technology, known as TwinRCT. This approach utilizes machine learning to create prognostic digital twins for individual patients, allowing for more accurate estimations of treatment effects while reducing the number of participants needed. The company also offers services for Clinical Trial Design, which helps determine inclusion criteria, endpoints, and study sizes, as well as Synthetic Control Arms that can minimize or eliminate the need for concurrent control groups. Additionally, Unlearn.AI provides Subgroup Analysis to identify and analyze specific patient subgroups within trial results. By integrating expertise from pharmaceuticals, medical technology, and machine learning, Unlearn.AI aims to transform clinical trials to improve outcomes for both patients and sponsors.

Founded in 2022, Harbor Health is a multi-specialty clinic group based in Austin, Texas. It offers personalized healthcare through technology, co-creating health paths tailored to individuals' goals with specialist guidance when needed.

Latent Labs is a pioneering AI laboratory specializing in programmable biology. It develops advanced generative AI models that capture the core principles of biology, empowering healthcare partners to create novel antibodies, optimize existing enzymes, and advance genetic engineering. This enables partners to gain unparalleled control over molecular biology, driving transformative advancements in health and sustainability.

Lind AI specializes in AI-driven trial matching for patients. It swiftly and accurately matches patients' medical records with suitable clinical trials, providing comprehensive eligibility evaluations and evidence documentation to healthcare providers. This process aims to expand treatment options for patients across various diseases, from cancer to diabetes, thereby enhancing patient-caregiver connections.

Nest Health is a family healthcare platform that brings medical services to the home through in-home and virtual visits. It serves patients across newborns, children, teens, and adults with a wide range of services including medical, behavioral health, and nutrition support, as well as preventive care, sick visits, and chronic disease management. The company aims to reduce the burden of arranging care by enabling patients to receive necessary treatments and consultations without leaving home, delivering convenient and accessible care in the familiar setting of the home.

Founded in 2022, Empassion Health specializes in providing comprehensive care services for patients with advanced illnesses. The company offers community-based care management tools and services, including patient enrollment, primary care visits, urgent care, goals planning, and social support, enabling patients to optimize their daily lives and maintain independence at home.

Amber Therapeutics specializes in developing advanced bioelectronic therapies that can sense and adapt, aiming to enhance clinical outcomes for patients with functional disorders of the peripheral nervous system.

Oula Health, Inc. is a maternity care provider based in Brooklyn, New York, established in 2019. The company focuses on redesigning maternity care by integrating obstetrics and midwifery to create a personalized and evidence-based experience for expecting families. Oula operates clinics and offers home-based prenatal care services, aiming to set a new standard for pregnancy care that harmonizes modern medical practices with a compassionate approach. Through its innovative model, Oula Health seeks to enhance the overall maternity care experience for its clients.

Galileo is a technology company based in New York, founded in 2014, specializing in healthcare solutions. The company offers a mobile application and online communication platform that enables medical professionals to provide comprehensive clinical care directly from their phones. This includes synchronous and asynchronous telecommunications technologies for connecting providers with patients. Galileo's services cater to diverse patient populations, offering high-touch, data-driven, multi-specialty longitudinal care over the phone, at home, and in various settings. The company is recognized by regional and national health plans, employers, and Fortune 500 companies as a leading solution for improving population health.

Hexagon Bio, Inc. is a biotechnology company that specializes in discovering novel small molecule therapeutics by mining genomic data from fungal genomes. Founded in 2016 and headquartered in Menlo Park, California, Hexagon Bio leverages a proprietary platform that integrates data science, synthetic biology, and automation to identify and engineer drugs. The company's innovative approach focuses on developing targeted therapies for diseases with unmet medical needs by searching for evolutionarily refined molecules and their associated protein targets. Through its unique methodology, Hexagon Bio aims to uncover new medicines encoded within the global metagenome, ultimately striving to improve patient outcomes.

Our mission is to redefine the standard of care in pulmonary medicine and deliver the best lung care in America. We’re rebuilding the pulmonary clinic around a technology platform and a set of virtual and physical interventions calibrated to keep lung conditions under control. At a Nimbus Clinic, rich patient data and predictive models allow our providers to make more thoughtful medical decisions, and step in at exactly the right moment.

Founded in 2022, Harbor Health is a multi-specialty clinic group based in Austin, Texas. It offers personalized healthcare through technology, co-creating health paths tailored to individuals' goals with specialist guidance when needed.

Digital Diagnostics is a pioneering company developing artificial intelligence-based diagnostic systems for medical images. It offers solutions such as IDx-DR for diabetic retinopathy, IDx-G for glaucoma indicators, and IDx-AMD for age-related macular degeneration detection. The company's autonomous AI platform aims to improve healthcare accessibility, equity, and affordability by making clinical decisions without human intervention.

KeyCare is a virtual care platform that leverages the Epic system to support health systems in enhancing patient access and quality of care. The platform is designed to provide a tech-driven virtual care team that supplements existing healthcare workforces, thereby broadening the options available for virtual care. By focusing on increasing accessibility and improving care quality, KeyCare aims to meet the needs of patients and healthcare providers in a rapidly evolving healthcare landscape.

Cartography Biosciences specializes in developing precision cancer immunotherapies. It employs single-cell analysis to identify novel targets for Chimeric Antigen Receptor T-cell (CAR-T) therapies, aiming to enhance safety and efficacy.

Senti Biosciences is a biotechnology company focused on synthetic biology. It develops gene circuit platforms to engineer therapeutics, with a focus on improving precision and control in cancer treatments.

Amae Health is a clinic specializing in mental wellness care for individuals with severe mental illnesses. It offers tailored treatments across behavioral medicine, primary care, and social health services, aiming to stabilize patients, enhance their well-being, and prevent future crises. The company's integrated care platform is designed to address the unique needs of its patients, enabling improved health outcomes.

Unlearn.AI, Inc. is a biotechnology company based in San Francisco, California, that specializes in developing innovative software tools for clinical research. Established in 2017, Unlearn.AI focuses on enhancing clinical trials through its unique digital twin technology, known as TwinRCT. This approach utilizes machine learning to create prognostic digital twins for individual patients, allowing for more accurate estimations of treatment effects while reducing the number of participants needed. The company also offers services for Clinical Trial Design, which helps determine inclusion criteria, endpoints, and study sizes, as well as Synthetic Control Arms that can minimize or eliminate the need for concurrent control groups. Additionally, Unlearn.AI provides Subgroup Analysis to identify and analyze specific patient subgroups within trial results. By integrating expertise from pharmaceuticals, medical technology, and machine learning, Unlearn.AI aims to transform clinical trials to improve outcomes for both patients and sponsors.

Candid Health is a platform that automates revenue cycle management for healthcare providers by integrating with existing infrastructure and using machine learning and artificial intelligence to streamline medical billing, coding, and claims processing. It delivers end-to-end automation to reduce administrative burdens, increase operational efficiency, and accelerate reimbursement, enabling clinics and hospitals to focus more on delivering high-quality, affordable care.

Movet is a veterinary clinic that specializes in providing comprehensive care for pets through both in-person and remote services. The clinic offers general consultations, vaccinations, wound treatments, and surgical procedures, ensuring a wide range of healthcare options for animals. In addition to traditional veterinary services, Movet leverages a telemedicine platform that facilitates remote consultations via chat and video calls, allowing pet owners to access care conveniently. The platform also includes home services such as emergency transfers, delivery of medications, laboratory tests, and diagnostic imaging, enhancing the overall well-being of pets by making veterinary care more accessible.

Ritten specializes in providing an electronic medical records platform tailored for addiction treatment providers. Its platform offers customizable workflow configurations to ensure consistent, compliant care delivery, enabling clinicians and administrators to maintain comprehensive patient records that track clinical notes, medications, and treatment plans, thereby facilitating personalized, data-informed care.

Pair Team provides healthcare coordination services focused on underserved and vulnerable communities. It deploys a dedicated, tech-enabled care team—including community health workers, registered nurses, and behavioral health clinicians—to offer personalized, holistic support to Medicaid and Medicare patients and other low-income individuals facing barriers to care such as transportation, housing and food insecurity, and limited mobile access. The company acts as an extension of safety-net primary care systems, helping them deliver patient-centered care while integrating with community-based organizations. It is building a care delivery platform to standardize clinical practices, streamline administrative tasks, and enable clinicians to spend more time with patients.

SurgLogs Inc. is a software developer based in San Diego, California, specializing in compliance-related solutions for ambulatory surgery centers and healthcare facilities. Founded in 2015, the company provides a digital platform that replaces traditional pen-and-paper methods with a HIPAA-compliant application and an administrative dashboard. This platform organizes and automates the management of logbooks, medications, supplies, in-services, and drills, enhancing efficiency and reducing paperwork for healthcare organizations. SurgLogs offers features such as device authorization, automated daily checks and notifications, and electronic report export services, catering to doctors, nurses, and healthcare administrators. By streamlining compliance processes, SurgLogs enables its clients to maintain regulatory standards effectively and manage operations more efficiently.

Founded in 2017 by Dr. Matthew Hill, Elegen is a biotechnology company specializing in microfluidic technology for the development of advanced DNA synthesizers. Its mission is to accelerate biomedical progress through innovative synthetic biology solutions.

Founded in San Francisco, Sirona Medical develops a cloud-native platform designed specifically for radiologists. This platform unifies worklist, viewer, reporter, archive, and AI into a single workspace, simplifying complex workflows, enhancing productivity, and empowering practitioners to deliver better, faster care.

Immunai develops an AI-based immune profiling platform for drug discovery, diagnosis, and treatment. It offers multi-omic single-cell genomics with machine learning algorithms, enabling high-resolution profiling of the immune system at scale. Immunai partners with academic institutions and biopharmaceutical companies to accelerate research and development in immunology.

Better Health is a digital platform facilitating peer-to-peer support and supplies management for individuals with chronic conditions such as ostomy, wounds, diabetes, retention, and incontinence. Trusted by major healthcare payers and providers, it improves patient outcomes and reduces care costs through education, engagement, and adherence.

Melvi is a Brazilian marketplace founded in 2021 by Mariana Paixão, Marcela Sobrinho, and Nino Vashakidze, headquartered in São Paulo. The platform connects patients with clinics, allowing them to easily find and book same-day appointments tailored to their needs at affordable prices. Melvi serves as a resource for patients seeking consultations across various medical specialties, including psychiatry, psychology, and nutrition. Additionally, it enhances clinic occupancy rates by driving a steady volume of new patients. The platform also offers a range of services, including remote consultations and discounted examinations, with convenient online payment options.

Examedi is a healthcare startup that facilitates at-home medical services by connecting patients with independent healthcare providers, including nurses and lab technicians. The company's telemedicine platform allows patients to book diagnostic tests and examinations from the comfort of their homes, focusing on services such as blood tests, pregnancy tests, general check-ups, and COVID-19 testing. By streamlining the scheduling process and offering affordable access to various medical tests, Examedi aims to enhance patient convenience and improve healthcare delivery.

Hexagon Bio, Inc. is a biotechnology company that specializes in discovering novel small molecule therapeutics by mining genomic data from fungal genomes. Founded in 2016 and headquartered in Menlo Park, California, Hexagon Bio leverages a proprietary platform that integrates data science, synthetic biology, and automation to identify and engineer drugs. The company's innovative approach focuses on developing targeted therapies for diseases with unmet medical needs by searching for evolutionarily refined molecules and their associated protein targets. Through its unique methodology, Hexagon Bio aims to uncover new medicines encoded within the global metagenome, ultimately striving to improve patient outcomes.

Maximus is a consumer telemedicine company for men’s health and hormone optimization. Maximus is revolutionizing the performance enhancement space by democratizing doctor-prescribed protocols developed by some of the world’s leading experts in men’s health. Maximus’ King Protocol utilizes a convenient prescription medication capsule to stimulate natural testosterone production, proven by at-home lab tests. Maximus was established in 2020 by Cameron Sepah in Santa Monica, California.

Appia Bio is a biotechnology company dedicated to the research and development of off-the-shelf allogeneic cell therapies, with a particular focus on engineered allogeneic cell therapies for various medical indications. The company utilizes its proprietary ACUA technology platform to harness the biology of lymphocyte development, integrating chimeric antigen receptor (CAR) and T-cell receptor (TCR) gene engineering. This innovative approach allows Appia Bio to generate CAR-engineered invariant natural killer T (CAR-iNKT) cell subtypes derived from hematopoietic stem cells (HSCs). By maturing and scaling healthy stem cells into invariant T-cell therapies, Appia Bio aims to provide physicians with safe and targeted cancer treatment options, thereby expanding patient access to advanced therapeutic solutions.

DocStation, Inc. is a cloud-based patient care platform headquartered in Austin, Texas, that was established in 2017. The company focuses on connecting payers and pharmacists to facilitate value-based care programs, which aim to reduce healthcare costs and enhance patient outcomes. Its platform equips pharmacists with essential tools, including a comprehensive dashboard that consolidates patient information such as diagnoses, medications, immunizations, allergies, and adverse events. This integration allows pharmacists to create care plans, set goals, monitor patient adherence, and schedule follow-ups, thereby enabling real-time connections with patients. With over 500 providers collaborating with innovative health plans on the platform, DocStation is positioned to transform the pharmacy landscape by aligning the interests of all stakeholders involved in patient care.

Better Health is a digital platform facilitating peer-to-peer support and supplies management for individuals with chronic conditions such as ostomy, wounds, diabetes, retention, and incontinence. Trusted by major healthcare payers and providers, it improves patient outcomes and reduces care costs through education, engagement, and adherence.

Acepodia is a clinical-stage biotechnology company focused on developing innovative, first-in-class cell therapies for cancer treatment. The company utilizes its proprietary Antibody-Cell Conjugation (ACC) platform technology to attach tumor-targeting antibodies directly to immune cell receptors, enhancing the interaction between immune and cancer cells. This approach generates highly specific and potent cell therapies without requiring genetic engineering. Acepodia is dedicated to expanding its research, clinical development, and manufacturing capabilities to provide effective immunotherapeutic strategies against various types of cancer. The company maintains a broad pipeline portfolio, each targeting different cancer indications.

Senti Biosciences is a biotechnology company focused on synthetic biology. It develops gene circuit platforms to engineer therapeutics, with a focus on improving precision and control in cancer treatments.

Dren Bio is a biotechnology company that specializes in protein engineering technologies aimed at depleting pathogenic cells, protein aggregates, and other disease-causing agents. The company operates under a holding business model, developing a diverse portfolio of projects that function as stand-alone assets. Dren Bio's platform is designed to address a range of health conditions, including hematologic neoplasms, solid tumors, autoimmune disorders, and diseases associated with protein aggregation. By focusing on innovative protein-based technologies, Dren Bio enables healthcare professionals to manage and treat various serious diseases more effectively.

Sonoma Pharmaceuticals, Inc. is a specialty pharmaceutical company based in Woodstock, Georgia, focused on developing and producing stabilized hypochlorous acid (HOCl) products for a range of applications, including wound care, dermatology, animal health, eye care, and oral care. With over 100 products commercialized in 33 countries, Sonoma addresses unmet medical needs through its innovative therapies aimed at chronic skin conditions. Key offerings include Epicyn, an antimicrobial facial cleanser; Levicyn, a prescription product for dermatoses; Celacyn gel for scar management; and SebuDerm for seborrheic dermatitis. Additionally, the company provides Microcyn, which targets various pathogens to promote wound healing, and Acuicyn, designed for eye care. Sonoma Pharmaceuticals was formerly known as Oculus Innovative Sciences, Inc. and has been incorporated since 1999. Its commitment to improving patient care and reducing healthcare costs is reflected in its diverse product portfolio that caters to both prescription and non-prescription needs.

Sonoma Biotherapeutics, Inc. is focused on developing adoptive T regulatory (Treg) cell therapies aimed at treating autoimmune and degenerative diseases. Established in 2019 and based in South San Francisco, California, with an additional office in Seattle, the company employs next-generation genome editing and target-specific cell therapy techniques to innovate in the field of Treg cell therapeutics. The firm aims to create disease-modifying and potentially curative therapies that promote self-tolerance and inhibit harmful inflammatory responses associated with conditions such as rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, amyotrophic lateral sclerosis, and Alzheimer's disease. Founded by experts in Treg biology and cell therapy, Sonoma Biotherapeutics integrates advanced methodologies to enhance its therapeutic offerings.

Hexagon Bio, Inc. is a biotechnology company that specializes in discovering novel small molecule therapeutics by mining genomic data from fungal genomes. Founded in 2016 and headquartered in Menlo Park, California, Hexagon Bio leverages a proprietary platform that integrates data science, synthetic biology, and automation to identify and engineer drugs. The company's innovative approach focuses on developing targeted therapies for diseases with unmet medical needs by searching for evolutionarily refined molecules and their associated protein targets. Through its unique methodology, Hexagon Bio aims to uncover new medicines encoded within the global metagenome, ultimately striving to improve patient outcomes.

Founded in San Francisco, Sirona Medical develops a cloud-native platform designed specifically for radiologists. This platform unifies worklist, viewer, reporter, archive, and AI into a single workspace, simplifying complex workflows, enhancing productivity, and empowering practitioners to deliver better, faster care.

Orca Bio is a clinical-stage cell therapy company focused on providing curative treatments for patients with various malignant and autoimmune diseases. The company has developed a range of proprietary technologies aimed at replacing diseased blood and immune systems with healthy ones. By specializing in the research and development of innovative cell therapies, Orca Bio seeks to transform the landscape of bone marrow transplantation. Its advanced therapeutic platform is designed to empower healthcare professionals in effectively treating patients, thereby addressing a significant unmet medical need. The company is backed by a team of leading experts and technologists committed to realizing its vision of delivering life-saving medical solutions.

Swiftscale Biologics is a healthcare service provider based in South San Francisco, California, founded in 2019. The company specializes in cell-free protein synthesis, focusing on rapid expression, high-throughput synthesis, and the production of complex proteins. Its innovative platform is designed to test and develop antibodies that inhibit the interaction between viral proteins and human host cells, effectively stopping ongoing coronavirus infections. By advancing these life-saving drugs, Swiftscale Biologics aims to enhance patient outcomes and improve overall health.

Mindstrong Health, established in 2013 and based in Mountain View, California, specializes in remote mental health care. It offers a digital therapeutic platform that combines AI-powered technology, data, and clinical expertise to monitor and improve users' mental health. The platform tracks symptoms continuously through passive data collection from human-computer interactions, enabling evidence-based interventions and personalized support. Services include cognitive behavioral therapy, psychoeducation, crisis management, and more, helping thousands of users, including those with serious mental illness.

Unlearn.AI, Inc. is a biotechnology company based in San Francisco, California, that specializes in developing innovative software tools for clinical research. Established in 2017, Unlearn.AI focuses on enhancing clinical trials through its unique digital twin technology, known as TwinRCT. This approach utilizes machine learning to create prognostic digital twins for individual patients, allowing for more accurate estimations of treatment effects while reducing the number of participants needed. The company also offers services for Clinical Trial Design, which helps determine inclusion criteria, endpoints, and study sizes, as well as Synthetic Control Arms that can minimize or eliminate the need for concurrent control groups. Additionally, Unlearn.AI provides Subgroup Analysis to identify and analyze specific patient subgroups within trial results. By integrating expertise from pharmaceuticals, medical technology, and machine learning, Unlearn.AI aims to transform clinical trials to improve outcomes for both patients and sponsors.

WellPay, Corp. is a healthcare financial technology company that offers a digital platform designed to assist independent medical practices and their patients in managing billing processes. Founded in 2019 and headquartered in San Mateo, California, with additional offices in Raleigh, North Carolina, and Columbia, Maryland, WellPay enables healthcare providers across various sectors—including urgent care, primary care, anesthesiology, dermatology, radiology, obstetrics, psychiatry, sports rehabilitation, and chiropractic—to send and manage bills efficiently. The platform helps billers collect patient balances with real-time reporting and activity management while providing patients with easy-to-understand medical bills and convenient payment options. This modern approach enhances transparency and streamlines the billing experience for both providers and patients.

Candid Health is a platform that automates revenue cycle management for healthcare providers by integrating with existing infrastructure and using machine learning and artificial intelligence to streamline medical billing, coding, and claims processing. It delivers end-to-end automation to reduce administrative burdens, increase operational efficiency, and accelerate reimbursement, enabling clinics and hospitals to focus more on delivering high-quality, affordable care.

Sonoma Biotherapeutics, Inc. is focused on developing adoptive T regulatory (Treg) cell therapies aimed at treating autoimmune and degenerative diseases. Established in 2019 and based in South San Francisco, California, with an additional office in Seattle, the company employs next-generation genome editing and target-specific cell therapy techniques to innovate in the field of Treg cell therapeutics. The firm aims to create disease-modifying and potentially curative therapies that promote self-tolerance and inhibit harmful inflammatory responses associated with conditions such as rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, amyotrophic lateral sclerosis, and Alzheimer's disease. Founded by experts in Treg biology and cell therapy, Sonoma Biotherapeutics integrates advanced methodologies to enhance its therapeutic offerings.

SurgLogs Inc. is a software developer based in San Diego, California, specializing in compliance-related solutions for ambulatory surgery centers and healthcare facilities. Founded in 2015, the company provides a digital platform that replaces traditional pen-and-paper methods with a HIPAA-compliant application and an administrative dashboard. This platform organizes and automates the management of logbooks, medications, supplies, in-services, and drills, enhancing efficiency and reducing paperwork for healthcare organizations. SurgLogs offers features such as device authorization, automated daily checks and notifications, and electronic report export services, catering to doctors, nurses, and healthcare administrators. By streamlining compliance processes, SurgLogs enables its clients to maintain regulatory standards effectively and manage operations more efficiently.

Nines is a pioneering teleradiology practice that focuses on enhancing patient care through advanced technology. The company develops in-house tools that empower radiologists to provide high-quality diagnostics. Its platform is designed to analyze medical scans for urgent findings that necessitate immediate attention, as well as to identify subtle details that assist in the radiological review process. This innovative approach aims to improve the accuracy of results and overall patient care, setting Nines apart in the field of radiology.

Deciduous Therapeutics is a biotechnology company focused on developing innovative immune-modulatory therapies aimed at addressing age-related diseases. The company specializes in creating novel molecules that activate the body's natural immune surveillance mechanisms to selectively eliminate senescent cells, which are associated with various age-related conditions. Led by Anil Bhushan, a professor at UCSF, and Robin Mansukhani, an experienced biotech entrepreneur, Deciduous Therapeutics is dedicated to promoting a healthier lifespan through its pioneering approach to therapeutics in the aging sector.

Acutus Medical designs, manufactures, and markets tools for catheter-based ablation procedures to treat various cardiac arrhythmias worldwide. Its product portfolio includes access sheaths, transseptal crossing tools, diagnostic catheters, ablation catheters, mapping consoles, and supporting software.

Swiftscale Biologics is a healthcare service provider based in South San Francisco, California, founded in 2019. The company specializes in cell-free protein synthesis, focusing on rapid expression, high-throughput synthesis, and the production of complex proteins. Its innovative platform is designed to test and develop antibodies that inhibit the interaction between viral proteins and human host cells, effectively stopping ongoing coronavirus infections. By advancing these life-saving drugs, Swiftscale Biologics aims to enhance patient outcomes and improve overall health.

Hims & Hers is a telehealth platform connecting consumers with licensed medical professionals for accessible, convenient healthcare. Initially focused on telemedicine services like erectile dysfunction and hair loss treatments, the company expanded to cover mental health, dermatology, primary care, and more.

Digital Diagnostics is a pioneering company developing artificial intelligence-based diagnostic systems for medical images. It offers solutions such as IDx-DR for diabetic retinopathy, IDx-G for glaucoma indicators, and IDx-AMD for age-related macular degeneration detection. The company's autonomous AI platform aims to improve healthcare accessibility, equity, and affordability by making clinical decisions without human intervention.

Mammoth Biosciences harnesses diverse CRISPR systems for various applications. It offers DETECTR™ for nucleic acid detection in diseases like cancer and infections, and CRISPR-Cas systems for therapeutic genome editing in immuno-oncology, autoimmune diseases, and liver disorders. Its solutions span healthcare, agriculture, environmental monitoring, biodefense, and other sectors.

Serotiny, Inc. is a biotechnology company based in San Francisco, California, focused on the design and development of multi-domain proteins and therapies aimed at treating cancers and genetic disorders. Founded in 2014, Serotiny leverages a unique platform that integrates synthetic biology with advanced informatics to facilitate the rational design of proteins. The company specializes in creating therapeutic proteins for CAR T-cell therapies and other cellular therapies. By harmonizing computational protein design, high-throughput cellular assays, and next-generation sequencing, Serotiny employs a cross-disciplinary approach that incorporates expertise from immunology, machine learning, software engineering, and bioinformatics. This innovative methodology enables the development of gene and cell therapies with improved safety and efficacy through novel control mechanisms and engineered functionalities.

Opencare Inc. is a healthcare discovery platform based in Toronto, Canada, that facilitates connections between patients and healthcare providers across North America. Founded in 2012 and initially known as HealthKiwi Inc., Opencare specializes in the dental sector, creating a premium dental care network that ensures patients receive high-quality care from top dentists. The platform simplifies the process of finding and booking appointments with various healthcare providers, including dentists, chiropractors, massage therapists, physiotherapists, and optometrists. By streamlining interactions between patients and providers, Opencare aims to enhance the overall patient experience in accessing healthcare services.

Notable is an artificial intelligence platform for healthcare operations that automates administrative and operational tasks within health systems, clinics, and other care settings. The platform handles patient intake, scheduling, prior authorization, documentation, and billing automation, enabling providers and staff to streamline workflows and reduce manual workload for more efficient care delivery. It is deployed at over 10,000 sites of care and automates a million repetitive workflows daily across Registration and Intake, Scheduling and Referrals, Assistant, Authorizations, Care Gap Closure, and HCC Chart Review, leading to faster patient processing, improved care coordination, and stronger financial performance for healthcare organizations.

Coral Genomics, Inc. is a biotechnology company founded in 2018 and headquartered in San Francisco, California. The company focuses on optimizing drug development and deployment by leveraging genomic data from patients. It specializes in developing clinical tests that assist healthcare providers in streamlining prior authorization processes and selecting effective medications tailored to individual patients, particularly in the context of autoimmune conditions like Inflammatory Bowel Disease and Rheumatoid Arthritis. Additionally, Coral Genomics has identified a distinct group of non-responder patients and collaborates with pharmaceutical developers to address the unmet medical needs of this population. By measuring cell responsiveness to drugs and understanding variability across patients, Coral Genomics aims to enhance treatment strategies and improve patient outcomes.

PathAI, Inc. is a technology company that specializes in developing artificial intelligence solutions for pathology laboratories. Founded in 2016 and headquartered in Boston, Massachusetts, with an additional office in Austin, Texas, PathAI focuses on enhancing the accuracy and efficiency of cancer diagnosis and treatment. The company's platform employs machine and deep learning techniques to analyze large datasets, assisting pathologists in making rapid and precise diagnoses for patients. By addressing complex challenges in pathology, PathAI aims to facilitate personalized medicine and improve patient outcomes by identifying individuals who may benefit from innovative therapies.

Hexagon Bio, Inc. is a biotechnology company that specializes in discovering novel small molecule therapeutics by mining genomic data from fungal genomes. Founded in 2016 and headquartered in Menlo Park, California, Hexagon Bio leverages a proprietary platform that integrates data science, synthetic biology, and automation to identify and engineer drugs. The company's innovative approach focuses on developing targeted therapies for diseases with unmet medical needs by searching for evolutionarily refined molecules and their associated protein targets. Through its unique methodology, Hexagon Bio aims to uncover new medicines encoded within the global metagenome, ultimately striving to improve patient outcomes.

Mammoth Biosciences harnesses diverse CRISPR systems for various applications. It offers DETECTR™ for nucleic acid detection in diseases like cancer and infections, and CRISPR-Cas systems for therapeutic genome editing in immuno-oncology, autoimmune diseases, and liver disorders. Its solutions span healthcare, agriculture, environmental monitoring, biodefense, and other sectors.

Guardant Health is a precision oncology company specializing in blood tests and analytics. It provides liquid biopsy tests like Guardant360 for advanced cancer detection, GuardantOMNI for broader gene panels, LUNAR-1 for minimal residual disease detection, and LUNAR-2 for early cancer detection. The company also offers development services to biopharmaceutical companies.

Blink Health LLC is a digital platform that facilitates the online purchase of prescription medications at lower prices. Founded in 2014 and headquartered in New York, the service allows users to search for their medical prescriptions and either pick them up at local pharmacies across the United States or have them delivered to their homes. By providing access to discounted medications, Blink Health aims to make prescription drugs more affordable and accessible to millions of people. Through its user-friendly web application, the company seeks to streamline the medication purchasing process, enabling customers to save both time and money.

SyntheX specializes in drug discovery using synthetic biology platforms. It identifies protein interaction modulators and enables functional protein degradation, focusing on unique mechanisms for cancer and rare disease treatments.

PathAI, Inc. is a technology company that specializes in developing artificial intelligence solutions for pathology laboratories. Founded in 2016 and headquartered in Boston, Massachusetts, with an additional office in Austin, Texas, PathAI focuses on enhancing the accuracy and efficiency of cancer diagnosis and treatment. The company's platform employs machine and deep learning techniques to analyze large datasets, assisting pathologists in making rapid and precise diagnoses for patients. By addressing complex challenges in pathology, PathAI aims to facilitate personalized medicine and improve patient outcomes by identifying individuals who may benefit from innovative therapies.

Medal, Inc. is a healthcare company based in San Francisco, California, that specializes in providing administrator services. Established in 2015, the company focuses on the extraction, transportation, translation, and sharing of medical information. Medal’s services facilitate the efficient review, coordination, referral, analysis, billing, and auditing of healthcare data. As of July 2020, Medal operates as a subsidiary of CIOX Health, enhancing its capabilities in the healthcare information management sector.

Blink Health LLC is a digital platform that facilitates the online purchase of prescription medications at lower prices. Founded in 2014 and headquartered in New York, the service allows users to search for their medical prescriptions and either pick them up at local pharmacies across the United States or have them delivered to their homes. By providing access to discounted medications, Blink Health aims to make prescription drugs more affordable and accessible to millions of people. Through its user-friendly web application, the company seeks to streamline the medication purchasing process, enabling customers to save both time and money.

Founded in 2015 by leading microbiome experts, RondinX specializes in the development of an advanced drug discovery platform focused on microbiome therapeutics and companion diagnostics. The company employs a unique cloud-based computational pipeline known as the PTR (Peak-to-Trough) family of algorithms, which generates both static and dynamic insights into the bacterial ecosystem. This innovative technology aims to facilitate the discovery of targeted therapeutic solutions in the microbiome space, positioning RondinX as a key player in addressing emerging needs in healthcare related to microbiome-related conditions.

Call9, Inc. is a healthcare technology company based in Brooklyn, New York, that offers a mobile platform designed for nursing home patients to access emergency medical care. Since its incorporation in 2015, Call9 has developed a tele-EM platform that enables skilled nursing facility nurses to quickly connect with on-site Clinical Care Specialists and Board Certified Emergency Medicine Physicians during acute medical events. This innovative approach allows for expedited treatment and point-of-care diagnostics, significantly improving patient outcomes. By providing immediate care at the bedside, Call9 helps to keep over 80% of patients in their nursing home, thereby reducing unnecessary hospital transfers and saving substantial healthcare costs. The company's services are tailored to organizations with trained medical personnel, enhancing their ability to respond effectively to emergencies.